Creso Pharma Limited
COPHF · OTC
12/31/2023 | 6/30/2023 | 12/31/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $692 | – | $1,388 | – |
| Short-Term Investments | $0 | – | $0 | – |
| Receivables | $2,976 | – | $2,563 | – |
| Inventory | $1,461 | – | $5,773 | – |
| Other Curr. Assets | $391 | – | $0 | – |
| Total Curr. Assets | $5,520 | – | $9,724 | – |
| Property Plant & Equip (Net) | $9,655 | – | $9,978 | – |
| Goodwill | $3,462 | – | $0 | – |
| Intangibles | $133 | – | $15,848 | – |
| Long-Term Investments | $0 | – | $0 | – |
| Tax Assets | $0 | – | $0 | – |
| Other NC Assets | $274 | – | $2,432 | – |
| Total NC Assets | $13,524 | – | $28,258 | – |
| Other Assets | $0 | – | $0 | – |
| Total Assets | $19,044 | – | $37,982 | – |
| Liabilities | – | – | – | – |
| Payables | $8,964 | – | $2,827 | – |
| Short-Term Debt | $9,562 | – | $6,671 | – |
| Tax Payable | $0 | – | $0 | – |
| Deferred Revenue | $0 | – | $0 | – |
| Other Curr. Liab. | $4,492 | – | $375 | – |
| Total Curr. Liab. | $23,018 | – | $15,688 | – |
| LT Debt | $84 | – | $0 | – |
| Deferred Rev, NC | $0 | – | $0 | – |
| Deferred Tax Liab, NC | $0 | – | $0 | – |
| Other NC Liab. | $0 | – | $10,707 | – |
| Total NC Liab. | $84 | – | $10,707 | – |
| Other Liabilities | $0 | – | -$10,707 | – |
| Cap. Leases | $233 | – | $0 | – |
| Total Liabilities | $23,102 | – | $15,688 | – |
| Equity | – | – | – | – |
| Pref Stock | $0 | – | $0 | – |
| Common Stock | $150,470 | – | $128,382 | – |
| Retained Earnings | -$169,860 | – | -$126,598 | – |
| AOCI | $15,332 | – | $20,510 | – |
| Other Equity | $0 | – | $0 | – |
| Total Equity | -$4,058 | – | $22,294 | – |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | – | $0 | – |
| Total Liab. & Tot. Equity | $19,044 | – | $37,982 | – |
| Net Debt | $8,954 | $0 | $5,283 | $0 |